What's new?

Predicting communities with high tuberculosis case-finding efficiency to optimise resource allocation in Pakistan: comparing the performance

We’re thrilled to announce our recent breakthrough, as detailed in our article published in Tropical Medicine and Infectious Disease.

Predictive analytics has emerged as a powerful tool to forecast outcomes and make informed decisions in various fields. At EPCON, we are...

Accurately estimating the burden of disease and identifying risk factors are vital for efficient resource management in the ongoing fight...

Every year, World Malaria Day is observed on April 25th to raise awareness about the importance of continued investment and sustained...

We were excited to have had a sharing session on Friday 17th March with AQUITY Innovations, one of our key clients. This South African...

Tuberculosis (TB) is the second deadliest infectious killer worldwide. Daily, more than 4,100 people die from TB, a largely-treatable...

We are glad to announce the formation of our advisory board, which held its first meeting last week. The board consists of three...

Abdullah Latif, public health surveillance and data expert working for Mercy Corps in Pakistan, recently gave a fascinating virtual...

" The future looks bright: we are able to build AI models that can predict risk at the patient level and advise on personlized treatment...

"Making a difference to the health and lives of thousands of people across continents" Dr Sumbul Hashmi works as the Global Public Health...

To curb the spread of TB, it is vital to locate TB hotspots. EPCON assisted with this goal in southwest Nigeria, with the result that, to...

EPCON was excited that his CTO Thys Potgieter could present at this year’s the McGill Summer Institutes in Global Health programme....

Mobile Health (mHealth) solutions have been shown to have promising results in different disease domains. Use of mobile applications and...

Last week we had the opportunity to attend the StopTB Board Meeting at the Global Health Campus in Geneva. Although TB remains a global...